Form 8-K - Current report:
SEC Accession No. 0001564590-17-004905
Filing Date
2017-03-21
Accepted
2017-03-21 16:45:23
Documents
3
Period of Report
2017-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ABIO-FORM 8-K YEAR END RESULTS abio-8k_20170321.htm 8-K 30223
2 EX-99.1 abio-ex991_6.htm EX-99.1 94699
3 GRAPHIC g2017032022212118144535.jpg GRAPHIC 20861
  Complete submission text file 0001564590-17-004905.txt   155146
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 17704644
SIC: 2835 In Vitro & In Vivo Diagnostic Substances